BioLineRx Ltd.
(NASDAQ : BLRX)

( )
BLRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.82%27.9314.1%$164.34m
ICLRICON plc -0.61%224.274.2%$149.09m
JAZZJazz Pharmaceuticals Plc 1.21%175.902.2%$133.34m
HZNPHorizon Therapeutics Plc -0.96%86.565.5%$116.43m
CTLTCatalent, Inc. -2.34%101.572.1%$105.74m
BHCBausch Health Cos., Inc. 1.82%27.930.0%$88.73m
SAVACassava Sciences, Inc. -4.44%37.490.0%$55.76m
UTHRUnited Therapeutics Corp. 0.61%195.4914.0%$55.68m
PRGOPerrigo Co. Plc 3.29%45.806.9%$44.37m
BLRXBioLineRx Ltd. -7.60%2.920.8%$39.46m
ARGXargenx SE 0.37%258.210.0%$38.07m
SAGESAGE Therapeutics, Inc. -0.38%73.887.6%$35.36m
PCRXPacira Biosciences, Inc. 2.08%61.989.9%$26.35m
AXSMAxsome Therapeutics, Inc. -0.04%57.011.9%$26.03m
RVMDRevolution Medicines, Inc. 0.00%31.650.0%$24.96m

Company Profile

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which focuses on oncology. Its oncology programs include Motaxafortide (BL-8040), which is therapy platform used in the treatment of pancreatic cancer; and AGI-134 is a immunotherapy treatment used fro multiple solid tumors. The company was founded in April 2003 and is headquartered in Modi'in, Israel.